Bioactivity | Metrenperone is an inhibitor for 5-HT2 receptor. Metrenperone exhibits α1 and α2 antagonist activity as well as anti-H1 and anti-dopaminergic efficacy. Metrenperone can lower the blood pressure, enhances bradycardia in peripheral ischemia, inhibits serotonin-induced platelet aggregation, and antagonizes serotonin-mediated vasoconstriction. Metrenperone promotes the repair of acutely damaged collagen tissue[1][2]. |
CAS | 81043-56-3 |
Formula | C24H26FN3O2 |
Molar Mass | 407.48 |
Transport | Room temperature in continental US; may vary elsewhere. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. Oryan A, et al., Effects of a serotonin S2-receptor blocker on healing of acute and chronic tendon injuries. J Invest Surg. 2009 Jul-Aug;22(4):246-55. [2]. Linden A, et al., Cardiovascular response to intravenous administration of 5-hydroxytryptamine after type-2 receptor blockade, by metrenperone, in healthy calves. Vet J. 1999 Jan;157(1):31-7. |